Hormel Foods (HRL) came out with quarterly earnings of $0.34 per share, beating the Zacks Consensus Estimate of $0.32 per share. This compares to earnings of $0.35 per share a year ago.
Hormel Foods logged higher profit and revenue in its fiscal first quarter, as the steps it has taken to improve profitability are starting to yield results.
HRL's first-quarter results are likely to show modest sales growth, but elevated beef costs and turkey constraints may pressure earnings.
Hormel Foods is reshaping its portfolio with a strategic divestiture to boost profitability and focus on value-added protein offerings.
Hormel Foods Corporation (HRL) Presents at Consumer Analyst Group of New York Conference 2026 Prepared Remarks Transcript
HRL posts Q1 prelim sales of $3 billion with 2% organic growth and reaffirms fiscal 2026 outlook as it advances protein-focused strategy.
Hormel Foods sees improving earnings visibility into fiscal 2026 as pricing actions, cost cuts and efficiency gains begin to offset recent headwinds.
Beyond analysts' top-and-bottom-line estimates for Hormel (HRL), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended January 2026.
Hormel Foods Corporation (HRL) Shareholder/Analyst Call Transcript
HRL's International business highlights pockets of growth, with branded products gaining traction despite ongoing regional market challenges.
Consumer staples underperformed in a big way in 2025 but may see a more favorable environment in 2026 with easing sector-specific pressures and fiscal stimulus potentially boosting demand.
Hormel Foods is rated a Buy, trading near decade lows with a ~5% dividend yield and strong fundamentals. HRL targets 2–3% organic net sales growth and 5–7% operating income growth long-term, supported by portfolio optimization and protein focus. Free cash flow is expected to normalize following elevated CAPEX and inventory build-up in 2025, with the valuation estimating their fair value above current levels.